首页> 外文期刊>American journal of therapeutics >Approach to a Successful Selection of Antihypertensive Drugs for the Patient With Atherosclerosis
【24h】

Approach to a Successful Selection of Antihypertensive Drugs for the Patient With Atherosclerosis

机译:动脉粥样硬化患者成功选择降压药的途径

获取原文
获取原文并翻译 | 示例
           

摘要

Coronary heart disease has become a medical and public health issue associated with multiple risk factors such as age, diet, and sedentary life style. Associations between hypertension and atherosclerosis have been extensively studied, and several trials have demonstrated antiatherosclerotic properties in some of the most widely used antihypertensive agents. Hence, calcium channel block-ers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers have been the target for a number of controlled randomized trials studying its effect on atherosclerosis progression. Carotid intima-media thickness measurement by ultrasound is used as surrogate of atherosclerosis in most of these controlled trials. This review of the literature aims to summarize the most significant controlled trials involving antihypertensive therapy and atherosclerosis regression based on the carotid intima-media thickness measurement.
机译:冠心病已成为医学和公共卫生问题,与年龄,饮食和久坐的生活方式等多种风险因素有关。高血压和动脉粥样硬化之间的关联已被广泛研究,并且一些试验已经证明某些最广泛使用的降压药具有抗动脉粥样硬化特性。因此,钙通道阻滞剂,血管紧张素转化酶抑制剂和血管紧张素受体阻滞剂已成为许多研究其对动脉粥样硬化进展影响的随机对照试验的靶标。在大多数这些对照试验中,通过超声测量颈动脉内膜中层厚度被用作动脉粥样硬化的替代物。这篇文献综述旨在总结基于颈动脉内膜中层厚度测量的涉及降压治疗和动脉粥样硬化消退的最重要的对照试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号